Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5087338
Max Phase: Preclinical
Molecular Formula: C66H97N17O17S2
Molecular Weight: 1464.74
Molecule Type: Unknown
Associated Items:
ID: ALA5087338
Max Phase: Preclinical
Molecular Formula: C66H97N17O17S2
Molecular Weight: 1464.74
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2
Standard InChI: InChI=1S/C66H97N17O17S2/c1-7-34(3)51-62(97)78-45-32-101-102-33-46(60(95)81-53(37(6)85)63(98)72-36(5)54(89)76-44(31-84)58(93)80-52(35(4)8-2)65(100)83-26-14-19-48(83)64(99)82-25-13-18-47(82)61(96)79-51)77-56(91)41(17-12-24-69-66(67)68)74-57(92)43(27-38-15-10-9-11-16-38)73-50(88)30-70-49(87)29-71-55(90)42(75-59(45)94)28-39-20-22-40(86)23-21-39/h9-11,15-16,20-23,34-37,41-48,51-53,84-86H,7-8,12-14,17-19,24-33H2,1-6H3,(H,70,87)(H,71,90)(H,72,98)(H,73,88)(H,74,92)(H,75,94)(H,76,89)(H,77,91)(H,78,97)(H,79,96)(H,80,93)(H,81,95)(H4,67,68,69)/t34-,35-,36-,37+,41-,42+,43-,44-,45-,46-,47-,48-,51-,52-,53-/m0/s1
Standard InChI Key: YPYHWOCRLXKMBO-VNWDJCRVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1464.74 | Molecular Weight (Monoisotopic): 1463.6690 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Muratspahić E, Tomašević N, Koehbach J, Duerrauer L, Hadžić S, Castro J, Schober G, Sideromenos S, Clark RJ, Brierley SM, Craik DJ, Gruber CW.. (2021) Design of a Stable Cyclic Peptide Analgesic Derived from Sunflower Seeds that Targets the κ-Opioid Receptor for the Treatment of Chronic Abdominal Pain., 64 (13.0): [PMID:34162205] [10.1021/acs.jmedchem.1c00158] |
Source(1):